发明授权
US4795754A 3-(1H-tetrazol-5-y1)oxanilic acid and salts thereof and pharmaceutical compositions containing them 失效
3-(1H-四唑-5-基)恶嗪酸及其盐和含有它们的药物组合物

3-(1H-tetrazol-5-y1)oxanilic acid and salts thereof and pharmaceutical
compositions containing them
摘要:
A new compound, 3-(1H-tetrazol-5-yl)oxanilic acid and pharmaceutically acceptable salts thereof are herein disclosed, which can be prepared by reacting 3-(1H-tetrazol-5-yl)aniline with a compound represented by the general formula: A--CO--CO--B (wherein A and B may be identical with or different from one another and represent hydroxyl group, a halogen atom or a lower alkoxy group) and then optionally hydrolyzing the resultant product. The compound presents an excellent histamine and SRS-A release inhibitory effect and is hydrophilic or soluble in water. Therefore, the compound is very suitable to form, in particular, an aqueous pharmaceuticals for treatment or prevention of allergic diseases such as bronchial asthma, rhinitis and conjunctivitis.
公开/授权文献
信息查询
0/0